If you reach a plateau or your goals change, we adjust your doseup, down, or steadyto keep your treatment working for you
In the ACHIEVE-2 trial (Phase 3, 962 adults with type 2 diabetes on metformin), Orforglipron, a novel small-molecule oral GLP-1 RA went head-to-head against Dapagliflozin, one of the most widely used SGLT2 inhibitors
Its main job is to: Signal your pancreas to release insulin when blood sugar levels rise
Tirzepatide is a dual-action medication that activates GLP-1 and GIP receptors to curb appetite, enhance fat burning, and regulate blood sugar
For people on GLP-1 medications who are eating less and potentially not exercising enough , creatine provides a low-cost, evidence-based insurance policy for muscle tissue
Now that millions of people are taking these medications far beyond the scope of clinical trials researchers are beginning to understand why